| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
apolipoprotein L4 | 0.839 | 0.231 | 1.1E-03 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
GC vitamin D binding protein | 0.489 | 0.885 | 2.7E-11 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 1982 | 2015 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.500 | None | 0.887 | 4 | 0 | 1984 | 2020 | ||||||||
|
haptoglobin | 0.412 | 0.885 | 1.7E-05 |
|
disease | 0.350 | None | 1.000 | 1 | 0 | 1985 | 2020 | ||||||||
|
arginine vasopressin | 0.437 | 0.846 | 7.4E-02 |
|
disease | 0.380 | None | 1.000 | 1 | 0 | 1987 | 2018 | ||||||||
|
acid phosphatase 1 | 0.566 | 0.731 | 1.8E-08 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 1990 | 2017 | ||||||||
|
dopamine receptor D2 | 0.436 | 0.846 | 0.75 |
|
disease | 0.400 | None | 0.914 | 4 | 0 | 1991 | 2020 | ||||||||
|
tyrosinase | 0.473 | 0.808 | 5.0E-32 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 1991 | 2001 | ||||||||
|
histamine receptor H1 | 0.647 | 0.654 | 1.9E-06 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 1991 | 2002 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1991 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.700 | None | 0.895 | 2 | 0 | 1992 | 2019 | ||||||||
|
dopamine receptor D3 | 0.529 | 0.692 | 2.4E-03 |
|
disease | 0.500 | None | 0.841 | 1 | 0 | 1992 | 2020 | ||||||||
|
major histocompatibility complex, class I, C | 0.415 | 0.846 | 1.6E-06 |
|
disease | 0.380 | None | 1.000 | 2 | 1 | 1993 | 2018 | ||||||||
|
phenylalanine hydroxylase | 0.516 | 0.769 | 6.4E-23 |
|
disease | 0.370 | None | 1.000 | 2 | 0 | 1993 | 2018 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.480 | None | 0.500 | 2 | 5 | 1993 | 2019 | ||||||||
|
G protein subunit alpha o1 | 0.523 | 0.808 | 0.99 |
|
disease | 0.390 | None | 0.500 | 2 | 0 | 1993 | 2018 | ||||||||
|
dopamine receptor D4 | 0.517 | 0.577 | 9.3E-09 |
|
disease | 0.400 | None | 0.709 | 1 | 0 | 1993 | 2019 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.964 | 1 | 0 | 1993 | 2020 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
disease | 0.400 | None | 0.400 | 5 | 0 | 1994 | 2019 | ||||||||
|
glutamate ionotropic receptor kainate type subunit 1 | 0.641 | 0.462 | 1.2E-09 |
|
disease | 0.360 | None | 0.500 | 2 | 0 | 1994 | 2012 | ||||||||
|
interleukin 6 receptor | 0.471 | 0.846 | 3.2E-05 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 1994 | 2017 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 1994 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.400 | None | 0.950 | 1 | 0 | 1994 | 2020 | ||||||||
|
neurotrophin 3 | 0.519 | 0.808 | 0.93 |
|
disease | 0.400 | None | 0.778 | 1 | 0 | 1994 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
disease | 0.400 | None | 1.000 | 4 | 0 | 1995 | 2019 |